Join to View Full Profile
4800 Sand Point Way NESeattle, WA 98105
Phone+1 206-987-2106
Fax+1 206-987-3946
Dr. Cooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 2001 - 2004
USA HealthResidency, Pediatrics, 1998 - 2001
Nova Southeastern University College of Osteopathic MedicineClass of 1998
Certifications & Licensure
WA State License 2014 - 2025
AK State License 2021 - 2022
GA State License 2008 - 2016
AL State License 1999 - 2008
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
- Join now to see all
Publications & Presentations
PubMed
- Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeu...Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, Jemily Malvar, Kenneth M Heym
Pediatric Blood & Cancer. 2025-05-01 - New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, Nirali N Shah, André Baruchel
The Lancet. Oncology. 2025-04-01 - Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.Andrew E Place, Seth E Karol, Christopher J Forlenza, Todd M Cooper, Christopher Fraser
Pediatric Blood & Cancer. 2025-03-10
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML05312018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Navigating Treatment Options and Communication in Relapsed Pediatric AMLJune 1st, 2024- BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric LeukemiaFebruary 28th, 2022
- Viewing: CBDC Quality Program Charter, 13173October 11th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
